Paper32076403
Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine.
Iarkov A and 3 others. Front Aging Neurosci, 2020. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine. Papers, record 32076403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32076403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References293
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28720825 | Non-motor features of Parkinson disease. | Nat Rev Neurosci | 2017 | https://conductscience.org/library/papers/28720825 | PubMed |
| 2 | 25065439 | Direct and indirect pathways of basal ganglia: a critical reappraisal. | Nat Neurosci | 2014 | https://conductscience.org/library/papers/25065439 | PubMed |
| 3 | 2479133 | The functional anatomy of basal ganglia disorders. | Trends Neurosci | 1989 | https://conductscience.org/library/papers/2479133 | PubMed |
| 4 | 28954882 | Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial. | Neurology | 2017 | https://conductscience.org/library/papers/28954882 | PubMed |
| 5 | 30124146 | Emerging and Alternative Therapies For Parkinson Disease: An Updated Review. | Curr Pharm Des | 2018 | https://conductscience.org/library/papers/30124146 | PubMed |
| 6 | 23220289 | Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases. | Mol Cell Neurosci | 2013 | https://conductscience.org/library/papers/23220289 | PubMed |
| 7 | 30980444 | Non-viral nucleic acid delivery to the central nervous system and brain tumors. | J Gene Med | 2019 | https://conductscience.org/library/papers/30980444 | PubMed |
| 8 | 18245082 | Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18245082 | PubMed |
| 9 | 7700528 | Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. | Neuroscience | 1995 | https://conductscience.org/library/papers/7700528 | PubMed |
| 10 | 30093643 | Gene therapy for neurological disorders: progress and prospects. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/30093643 | PubMed |
| 12 | 19765180 | Neuronal cell replacement in Parkinson's disease. | J Intern Med | 2009 | https://conductscience.org/library/papers/19765180 | PubMed |
| 13 | 18359086 | Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. | Neurotoxicology | 2008 | https://conductscience.org/library/papers/18359086 | PubMed |
| 14 | 16018990 | Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. | Brain Res | 2005 | https://conductscience.org/library/papers/16018990 | PubMed |
| 15 | 21343917 | Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. | Mol Ther | 2011 | https://conductscience.org/library/papers/21343917 | PubMed |
| 16 | 19274089 | Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. | PLoS One | 2009 | https://conductscience.org/library/papers/19274089 | PubMed |
| 17 | 18821083 | Deep brain stimulation for parkinsonian gait disorders. | J Neurol | 2008 | https://conductscience.org/library/papers/18821083 | PubMed |
| 18 | 23241666 | The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context. | Rev Neurosci | 2013 | https://conductscience.org/library/papers/23241666 | PubMed |
| 19 | 30901512 | Recombinant Viral Vectors as Neuroscience Tools. | Curr Protoc Neurosci | 2019 | https://conductscience.org/library/papers/30901512 | PubMed |
| 20 | 10819950 | Association of coffee and caffeine intake with the risk of Parkinson disease. | JAMA | 2000 | https://conductscience.org/library/papers/10819950 | PubMed |
| 21 | 26113789 | Mitochondrial Dysfunction in Parkinson's Disease. | Exp Neurobiol | 2015 | https://conductscience.org/library/papers/26113789 | PubMed |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42776440 | Neuroprotection Across Cerebellar and Nigrostriatal Degeneration: Translational Insights from Parkinson's Disease to Spinocerebellar Ataxia Type 2. | Cerebellum | 2026 | https://conductscience.org/library/papers/42776440 | PubMed |
| 42725392 | Research advances in the microbiota‑gut‑brain axis and Parkinson's disease (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42725392 | PubMed |
| 42653806 | Pathogenesis-Driven Drug Repurposing with a Self-Nanoemulsifying Delivery System for Parkinson's Disease. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653806 | PubMed |
| 42455475 | Exosome Biology at the Interface of Neurodegeneration and Therapeutic Innovation. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42455475 | PubMed |
| 42404903 | Cholinergic regulation of neuroinflammation: linking microglia, immunometabolism, and neuromodulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42404903 | PubMed |
| 42231395 | Polymeric lysosome-targeting chimeras for extracellular α-synuclein degradation in Parkinson's disease. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42231395 | PubMed |
| 42168199 | Exploring fNIRS-guided neurofeedback for supplementary motor area training in Parkinson's disease and healthy older adults. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42168199 | PubMed |
| 42123771 | Ex Vivo Characterization and In Vivo Nasal Delivery of Ropinirole-Loaded PEO-b-PCL/Tween 80/β-Cyclodextrin Systems in C57BL/6J Mice. | Molecules | 2026 | https://conductscience.org/library/papers/42123771 | PubMed |
| 42106554 | Parkinson's disease severity is encoded by non-linear oscillatory interactions across cortical-subcortical networks. | Sci Rep | 2026 | https://conductscience.org/library/papers/42106554 | PubMed |
| 42095489 | Heterocyclic Derivatives in Parkinson's Therapy: Recent Advances and Prospects. | Med Chem | 2026 | https://conductscience.org/library/papers/42095489 | PubMed |
| 41968682 | Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson's Disease: A Comprehensive Review. | Curr Neuropharmacol | 2026 | https://conductscience.org/library/papers/41968682 | PubMed |
| 41559062 | Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse model. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41559062 | PubMed |
| 41409014 | Boron-Doped Nano-Crystalline Coated Carbon Fibers for Phasic Dopamine Sensing. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41409014 | PubMed |
| 40589144 | Psychosis in early onset Parkinson's disease: A retrospective cohort study in southeast Minnesota. | J Parkinsons Dis | 2025 | https://conductscience.org/library/papers/40589144 | PubMed |
| 40506444 | Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson's disease motor severity. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/40506444 | PubMed |
| 40488810 | The role of L-DOPA in neurological and neurodegenerative complications: a review. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/40488810 | PubMed |
| 40303506 | A Longitudinal Two-Armed Randomized Controlled Trial Protocol to Evaluate the Efficacy of Yoga on Progression of Disease in Early Parkinson's Disease. | Ann Neurosci | 2025 | https://conductscience.org/library/papers/40303506 | PubMed |
| 39580497 | A multi-region single nucleus transcriptomic atlas of Parkinson's disease. | Sci Data | 2024 | https://conductscience.org/library/papers/39580497 | PubMed |
| 39411956 | To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases. | Cent Nerv Syst Agents Med Chem | 2025 | https://conductscience.org/library/papers/39411956 | PubMed |
| 39346681 | Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics. | Front Mol Neurosci | 2024 | https://conductscience.org/library/papers/39346681 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32076403
GET https://conductscience.org/api/papers/v1/32076403/references?page=2